首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway.
【24h】

Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway.

机译:Lhermitte-Duclos病:31例PTEN / AKT / mTOR途径的免疫组织化学分析报告。

获取原文
获取原文并翻译 | 示例
       

摘要

Lhermitte-Duclos disease (LDD) is a rare cerebellar tumor associated with Cowden disease (CD) and germline mutations in the PTEN gene. To further define these relationships, we reviewed clinical and pathologic findings in 31 LDD cases and analyzed the status of the PTEN pathway in 11 of them. We hypothesized that the granule cell hypertrophy in LDD is secondary to activation of mammalian target of rapamycin (mTOR), a downstream effector in the PTEN/AKT pathway and a major regulator of cell growth. Histopathologically, in addition to the classical findings of LDD, we observed prominent vascular proliferation and vacuolization of the white matter in many of the lesions. Four patients met diagnostic criteria for CD, and many of the remaining patients had some clinical features of CD. Immunohistochemical analysis showed high levels of phospho-AKT and phospho-S6 in the large ganglionic cells forming the lesions, indicating activation of the PTEN/AKT/mTOR pathway and suggesting a central role for mTOR in thepathogenesis of LDD. These data support recommendations for genetic testing and screening for CD in patients with LDD and suggest a novel therapy for LDD through pharmacologic inhibition of mTOR.
机译:Lhermitte-Duclos病(LDD)是一种罕见的小脑肿瘤,与Cowden病(CD)和PTEN基因的种系突变有关。为了进一步定义这些关系,我们回顾了31例LDD病例的临床和病理发现,并分析了其中11例PTEN途径的状态。我们假设LDD中的颗粒细胞肥大是继发于雷帕霉素(mTOR),PTEN / AKT途径中的下游效应子和细胞生长的主要调节剂的哺乳动物靶标的激活。在组织病理学上,除了LDD的经典发现外,我们在许多病变中还观察到明显的血管增殖和白质的空泡化。四名患者符合CD的诊断标准,其余许多患者具有CD的某些临床特征。免疫组织化学分析显示,在形成病变的大神经节细胞中高水平的磷酸化AKT和磷酸化S6,表明PTEN / AKT / mTOR途径的激活,并暗示了mTOR在LDD发病机理中的重要作用。这些数据支持对LDD患者进行基因检测和CD筛查的建议,并建议通过药理抑制mTOR的方法来治疗LDD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号